name / content

name: Membership

Membership. The Executive Committee shall be constituted as follows: following its activation, the ISO shall have the right to appoint a non voting member of the Committee; each Participant whose Voting Share equals or exceeds 3% of the aggregate Voting Shares of all Participants shall have the right to appoint a voting member of the Committee; the remaining Participants whose Voting Shares are less than 3% of the aggregate Voting Shares of all Participants shall be divided into the following five groups, with each having the right to appoint one voting member of the Committee:
Membership. The Development Committee shall be comprised of an equal number of representatives from each of RPRP and Introgen, selected by such parties. The exact number of such representatives shall be three (3) for each of RPRP and Introgen, or such greater number as the parties may agree. Introgen and RPRP may replace its Development Committee representatives at any time, with written notice to the other party. From time to time, the Development Committee may establish subcommittees to oversee particular projects or activities, and such subcommittees will be constituted as the Development Committee agrees.
Membership. You automatically become a member of the Ramada Inns National Association ("RINA"), an unincorporated association. Other Chain licensees are also members of RINA. RINA may consider and discuss common issues relating to advertising and operation of facilities in the System and, through its Executive Committee, make recommendations to us regarding such issues and other matters.
Membership. The Executive shall, at the Company's request and expense, maintain a membership in the Real Estate Board of New York, Inc. The Executive will at all times adhere to the Code of Ethics and Professional Practices of said Board and to the requirements of all applicable laws and governmental regulations.
MEMBERSHIP. The RC shall include four (4) representatives of each of Daiichi and Pharmacopeia, each party's members selected by that party. The initial representatives of each party are listed on Exhibit B hereto. Pharmacopeia and Daiichi may each replace its RC representatives at any time, upon written notice to the other party. The RC shall be chaired as agreed by the parties. From time to time, the RC may establish subcommittees, such as a Patent Committee, to oversee particular projects or activities, and such subcommittees will be constituted as the RC agrees. It is understood that the "Patent Committee" shall be responsible for the patent matters arising out of the Research Program including, but not limited to, determination of inventorship and ...
Membership. Those Entities which are Participants in NEPOOL on the First Effective Date shall continue to be Participants.
Membership. There shall be a Management Committee which shall be constituted as follows: each Participant shall appoint and be represented by one member of the Management Committee.
MEMBERSHIP. The Company, by action of its Board of Directors, shall appoint a Committee of at least three persons to administer the Plan as hereinafter set forth. Upon his appointment to the Committee by the Company, each such appointee shall become a member of the Committee by accepting his appointment in a writing signed by him and delivered to the Company.
Membership. The R & D Committee shall consist of six (6) members, with three (3) members being appointed by each party. The initial R & D Committee members are:
Membership. Pfizer and Myco each shall appoint, in its sole discretion, three members to the Research Committee.
Membership. Takeda and Ovid shall each designate an equal number of representatives to serve on the CGB, JDC, JCC, JMC and any other Committee by written notice to the other Party. Promptly after the Effective Date, each Party shall designate two (2) such representatives for the CGB, JDC, JMC and JCC. Each Committee may elect to vary the number of representatives from time to time during the Term; provided that each Committee shall maintain an equal number of representatives from each Party. Each representative shall have the appropriate level of experience in the subject area of the Committee, and at least one (1) representative shall have sufficient seniority within the applicable Party?s organization to have the necessary decision making authority ...
Membership. The Plan will be administered by an Administrative Committee consisting of no less than three (3) nor more than eight (8) members appointed by the Company and the Plan investments may be directed by an Investment Committee consisting of no less than three (3) nor more than eight (8) members appointed by the Company. A Committee member may resign at any time by giving thirty (30) days' advance written notice to the Company and the other Committee members. The Company may remove a Committee member by giving advance written notice to him and the other Committee members. The members of both Committees may be identical, and if no members are appointed to the Investment Committee, the members of the Administrative Committee shall be deemed the ...
MEMBERSHIP. A person will become a Member upon designation by the Board of Directors. A Member's participation in the Plan may be terminated by action of the Board of Directors if the Member's position with the Company is changed.
Membership. Within ten (10) days of the date hereof, CBM and BIOGEN shall each appoint (2) persons (or such other number of persons as the parties may determine) to serve on the R&D Committee. Such representatives will be qualified, by reason of background and experience, to assess the scientific progress of each activity. Each party will have the right to change its representation on the R & D Committee upon written notice sent to the other party.
Membership. The Committee shall consist of at least three persons who shall be officers or directors of the Corporation or Eligible Employees. Members of the Committee shall be appointed from time to time by, and shall serve at the pleasure of, the Executive Committee of the Board. The Committee shall elect one of its members as chairman. The Committee shall not receive compensation for its services. Committee expenses shall be paid by the Corporation.
MEMBERSHIP. Membership in the Plan shall be comprised of those Executives appointed and approved as Members in the Plan, subject to the provisions of Section 4.2 below. Membership ceases at the end of the Plan Year.
Membership. The Steering Committee shall be comprised of an equal number of representatives from each of Ciba and Neurocrine, selected by such party. The exact number of such representatives shall be three (3) for each of Ciba and Neurocrine (or such other number as the parties agree), with each party designating representatives from the research, clinical development and business organizations of each party. Subject to the foregoing provisions of this Section 2.2, Neurocrine and Ciba may replace its Steering Committee representatives or nominate deputies at any time, with prior written notice to the other party.
Membership. Pfizer and Neurogen each shall appoint,in its sole discretion, four members to the Research Committee. Substitutes may be appointed at any time.
Membership. All Officers shall be Plan Members. The Compensation Committee may designate any other employee as a Plan Member. After an employee becomes a Plan Member, his membership shall continue until his death or Retirement, termination of his employment by the Company for Cause or Disability, or termination of his employment by such Plan Member other than for Good Reason.